Mike Mills

Mike Mills currently serves as Senior Director of Payer Access Special Accounts at Iovance Biotherapeutics, Inc. since September 2022. With extensive experience in market access within the oncology sector, Mike previously held roles at Kite Pharma, including Director of US Market Access and Payer Account Director, focusing on CAR T therapies. Prior to this, Mike was Associate Director at Merck Oncology, where responsibilities encompassed oncology reimbursement and healthcare policy, contributing to the successful launch of Keytruda across multiple indications. Mike began a longstanding career at Amgen, ultimately serving as Senior Manager in the Medicare Division, and has foundational experience in medical sales from early positions at Beecham Laboratories. Mike earned a B.S. in Psychology from James Madison University.